tranylcypromine has been researched along with Leukemia, Promyelocytic, Acute in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botrugno, OA; Brambillasca, S; Cappa, A; Cera, MR; Dessanti, P; Mercurio, C; Meroni, G; Minucci, S; Thaler, F; Trifirò, P; Varasi, M; Vianello, P; Villa, M; Zuffo, RD | 1 |
Botrugno, OA; Ciossani, G; Cirilli, R; Dessanti, P; Labella, D; Mai, A; Marrocco, B; Mattevi, A; Mercurio, C; Minucci, S; Monaldi, D; Rodriguez, V; Ruoppolo, G; Saponara, B; Tilset, M; Valente, S; Varasi, M; Vianello, P | 1 |
Botrugno, OA; Cappa, A; Dal Zuffo, R; Dessanti, P; Mai, A; Marrocco, B; Mattevi, A; Mercurio, C; Meroni, G; Minucci, S; Stazi, G; Thaler, F; Trifiró, P; Valente, S; Varasi, M; Vianello, P; Villa, M | 1 |
3 other study(ies) available for tranylcypromine and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
Novel potent inhibitors of the histone demethylase KDM1A (LSD1), orally active in a murine promyelocitic leukemia model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Histone Demethylases; Humans; Leukemia, Promyelocytic, Acute; Mice; Structure-Activity Relationship; Tranylcypromine | 2017 |
Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Histone Demethylases; Humans; Leukemia; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Tranylcypromine | 2015 |
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent.
Topics: Administration, Oral; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Histone Demethylases; Humans; Leukemia, Promyelocytic, Acute; Structure-Activity Relationship; Tranylcypromine | 2016 |